Search the Newsreel

Bilal Muhsin, Connected Care Segment, Becton Dickinson

Bilal Muhsin, Executive Vice President and President of the Connected Care Segment at Becton Dickinson (BD), discusses the evolution of connected care in hospitals, moving from episodic data to real-time, predictive insights. He highlights how BD's integrated platforms, like BD Incada, enable smarter alert …

Becton Dickinson earnings on deck as growth questions linger

Becton Dickinson (BD) is set to report its fiscal fourth-quarter earnings, with investors focused on the company's transformation into a pure-play medtech business. Analysts are looking for signs of sustainable mid-single-digit growth and improved operating leverage following the spin-off of its Biosciences and Diagnostic …

Levi & Korsinsky Reminds Embecta Corp. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 17, 2026 - EMBC

Levi & Korsinsky, LLP is reminding Embecta Corp. (NASDAQ: EMBC) investors of a pending class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal year 2026 revenue guidance and U.S. pen …

Is Becton Dickinson (BDX) Undervalued As Its Brazil Semaglutide Partnership Fuels Growth Hopes?

Becton Dickinson (BDX) is gaining attention due to its recent partnership with EMS to launch a semaglutide therapy in Brazil using its Vystra injection pen. Despite a 10.92% share price return over 90 days, the stock is down 15.04% year-to-date and trades below analyst …

Kaplan Fox Deadline Alert: Embecta Corp. (NASDAQ: EMBC) Investors Have Until August 17, 2026 to Seek a Lead Plaintiff Role

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit stems from a significant drop in Embecta's stock price after the …

Countdown to Becton Dickinson (BDX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Wall Street analysts forecast that Becton Dickinson (BDX) will report quarterly earnings of $3.14 per share in its upcoming release, pointing to a year-over-year decline of 14.7%. It is anticipated that revenues will amount to $4.89 billion, exhibiting a decrease of 11.2% compared to …

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A

Bernstein Liebhard LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its business, leading …

EMBC UPCOMING DEADLINE : The Gross Law Firm Alerts Embecta Corp. Stockholders of Securities Class Action - Contact the Firm

The Gross Law Firm has issued a notice to shareholders of Embecta Corp. (NASDAQ: EMBC) regarding a securities class action lawsuit. The lawsuit alleges that Embecta made misleading statements about its financial performance, particularly concerning its pen needle business, leading to a significant stock …

EMBC Stock Drop: Embecta Insulin Pen Issues Lead to 57% Stock Drop and Securities Fraud Class Action for Investors

|

Becton Dickinson & Co. stock outperforms competitors on strong trading day

Becton Dickinson & Co. (BDX) stock rose 2.77% to $170.21 on Monday, outperforming the broader market which also saw significant gains. This marks the second consecutive day of gains for the stock. The S&P 500 and Dow Jones Industrial Average also experienced strong trading …

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP is reminding investors of Embecta Corp. (EMBC) about an upcoming August 17, 2026 deadline to file a lead plaintiff motion in a class action lawsuit. The lawsuit alleges that Embecta made materially false and misleading statements between November …

EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

The Rosen Law Firm reminds investors who purchased Embecta Corp. (NASDAQ: EMBC) common stock between November 25, 2025, and May 4, 2026, of the upcoming August 17, 2026 lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Embecta made misleading statements …

Ludwig Beck Aktie: Open-Market-Aus geplant

Ludwig Beck: Umsatz sinkt auf 37,1 Millionen Euro

Is BD (BDX) Quietly Building a GLP-1 Delivery Moat With Its Brazil Semaglutide Partnership?

BD (Becton, Dickinson and Company) has partnered with EMS to launch a semaglutide therapy in Brazil using BD's Vystra Injection Pen, aiming to address the rising demand for GLP-1 therapies in chronic conditions like obesity and type 2 diabetes. This collaboration is seen as …

Embecta Corp. (EMBC) Faces Securities Class Action Over Insulin Pen Needle Disclosure - Investors with Losses Encouraged to Contact HBSS

Hagens Berman is investigating Embecta Corp. (EMBC) following a securities class action lawsuit alleging the company misrepresented the stability of its insulin pen needle business. The lawsuit claims Embecta's assurances of a "stable" business were false, as it was experiencing significant competitive share loss …

Embecta Corp. (NASDAQ:EMBC) Given Consensus Rating of "Reduce" by Analysts

Analysts have issued a consensus "Reduce" rating for Embecta Corp. (NASDAQ:EMBC), with an average 12-month price target of $11, though recent targets have been significantly lowered to $3-$5. The company recently reported weaker-than-expected Q1 earnings, missing EPS estimates and experiencing a 14.4% year-over-year revenue …

Embecta Corp. Revenue Breakdown – NASDAQ:EMBC

Embecta Corp. (NASDAQ: EMBC) outlines Owen Mumford deal terms and pro forma results

Embecta Corp. has outlined the detailed terms and pro forma financial results of its acquisition of Owen Mumford Holdings Limited, which was completed on May 15, 2026. The deal involved an upfront cash payment of £126.0 million ($166.1 million) and potential earn-out payments of …

Embecta (EMBC) Stock Drop: Robbins LLP Reminds Investors of Class Action and Urges Shareholders Who Lost Money to Contact the Firm

Robbins LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta misled investors about its financial outlook, particularly its pen needle …

Investors in Embecta Corp. (EMBC): Protect Your Rights - Contact Levi & Korsinsky Before August 17, 2026

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its financial …

Becton Dickinson & Co. stock underperforms Thursday when compared to competitors

Becton Dickinson & Co. (BDX) stock fell 1.75% on Thursday, closing at $165.45, despite an overall positive trading session for the broader market. This drop snapped a four-day winning streak for the company's shares. The S&P 500 Index and Dow Jones Industrial Average both …

Rhinebeck Bancorp Inc (RBKB) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Rhinebeck Bancorp Inc (RBKB), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. As of July 31, 2026, RBKB's price momentum score is 5.36, and it is trading between a resistance …

Lost Money on Embecta Corp. (EMBC)? Join Class Action Suit Seeking Recovery - Contact SueWallSt

SueWallSt has announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges false and misleading statements led to a 57.8% drop in Embecta's share value after …

Rhinebeck Bancorp, Inc. Revenue Breakdown – NASDAQ:RBKB

The article provides a revenue breakdown for Rhinebeck Bancorp, Inc. (NASDAQ: RBKB), highlighting that the greatest contribution to its revenue came from the United States. In the last financial year, the U.S. segment accounted for $53.36 million USD, an increase from $28.71 million USD …

RBKB|Rhinebeck Bancorp Inc|Price:12.310|Chg%:-0.100

Rhinebeck Bancorp Inc (RBKB) shows strong fundamentals with significant growth potential, although its stock price is expected to trend down in the medium term. The company's valuation is considered fair, and it has experienced consistent revenue and profit growth. Institutional ownership is high, and …

BD (BDX) Stock May Be 19% Undervalued On Fresh MedTech AI Adoption News

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Becton Dickinson stock has delivered a 20.9% one year return, yet the valuation checks send a mixed message, with the Discounted Cash Flow (DCF) …

Form 4 Rhinebeck Bancorp Inc For: 29 July By Investing.com

This article reports on a Form 4 filing for Rhinebeck Bancorp Inc. on July 29. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a material change in the holdings of company …

Rhinebeck Bank Appoints Travis Podolec as New Senior Vice President, Commercial Lender in Orange County

Rhinebeck Bank announced the appointment of Travis Podolec as Senior Vice President, Commercial Lender for its Orange County team. Podolec brings over 20 years of experience in commercial banking throughout the Hudson Valley and will focus on expanding the bank's commercial relationships in the …

EMBC INVESTOR ALERT: Embecta Corp. (EMBC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- Hagens Berman

Hagens Berman has initiated an investigation into Embecta Corp. (EMBC) following a class action lawsuit alleging misrepresentation of the commercial stability of its insulin pen needle business. The lawsuit claims Embecta misled investors about market share loss and volume softness, which led to a …

Kaplan Fox Notifies Embecta Corp. (EMBC) Investors of a Securities Class Action Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP has announced a securities class action lawsuit against Embecta Corp. (EMBC) for investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit stems from Embecta's Q2 fiscal 2026 results, which were significantly below expectations, leading …

EMBC Deadline Alert: Levi & Korsinsky Reminds Embecta Corp. (EMBC) Investors of Securities Class Action Deadline on August 17, 2026

Levi & Korsinsky, LLP is reminding investors of Embecta Corp. (NASDAQ: EMBC) about a securities class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misrepresentations regarding the stability of its U.S. pen needle revenue, which …

Becton Dickinson (BDX) On Its Brazil Semaglutide Push And The Valuation Narrative

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Becton Dickinson (BDX) is back in focus after announcing a collaboration with EMS to support the launch of a semaglutide therapy in Brazil. The …

EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch

Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients. FRANKLIN LAKES, N.J. and SÃO PAULO, July 29, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology …

A semaglutide therapy launches in Brazil with BD's injection pen

BD (Becton, Dickinson and Company) and EMS, a leading Brazilian pharmaceutical company, have collaborated to launch an EMS semaglutide therapy in Brazil using the BD Vystra™ Injection Pen platform. This partnership aims to enhance access to GLP-1 treatments for chronic metabolic diseases like obesity …

BDX.GJ Bond Profile — Key Metrics

This article provides a detailed profile of the BDX.GJ bond issued by Becton, Dickinson & Co. It outlines key metrics such as the issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate. The bond's profile is focused on the …